A method is described for inhibiting urokinase plasminogen activator in a human or animal patient. The method involves administering to the patient a urokinase plasminogen activator inhibiting effective amount of a compound of the formula (I): ##STR1##

 
Web www.patentalert.com

< Neuroprotective and retinoprotective ophthalmologic drugs

< Branched polymers and their conjugates

> Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients

> 2-aroylimidazole compounds for treating cancer
~ 00265